安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Homepage - Biosimilars Forum
The Biosimilars Forum is a nonprofit organization founded to advance biosimilars in the United States and expand access and availability of biological medicines
- Not So Different: The Biosimilars Forum Wants to Save the Healthcare . . .
Industry group the Biosimilars Forum recently put forth 3 policy proposals that it says could save the US healthcare system billions of dollars This week on the podcast, we’ve invited the forum to tell us more about its proposals and other policy issues related to biosimilars
- What Is The Biosimilars Forum? - Biosimilar Development
The Forum aims to provide information on the basic science behind biosimilars, as well as the regulatory science — what it takes to get a biosimilar approved In fact, the Forum recently launched a large educational initiative known as the “ Partnership for Biosimilars Education and Access ”
- Henlius Becomes Newest Member of Biosimilars Forum-Media
Recently, Henlius has been announced as the newest member company of the Biosimilars Forum, a coalition that advances biosimilars in United States with the intent of expanding access and availability of biological medicines and improving health care
- Tariffs could cancel out discounts with biosimilars
Tariffs on US pharma imports could remove discounts offered to health systems by biosimilars and threaten the future of the sector, according to a non-profit group
- ‘We Can’t Keep Going On Like This’ – Biosimilars Forum’s Reed Calls For . . .
As the US biosimilars market moves into its second decade, urgent changes are needed at the FDA if biosimilars are to meet their full potential, according to Biosimilars Forum chief executive Julie Reed
- News - Biosimilars Forum
July 8, 2021 Morning Consult: Expanding Access to Biosimilars Has Bipartisan Support But Movement on Legislation Hangs in the Balance of the Drug Pricing Debate
- About Us - Biosimilars Forum
The Biosimilars Forum will provide evidence-based information to inform and support public policies that encourage awareness, access, and adoption of biosimilars The introduction of biosimilars in the United States may help expand access to high-quality treatment options for clinicians and patients as well as potentially reduce costs to
|
|
|